New Hope for Depression Treatment in Lawrence, MA with Launch of TMS Therapy

Struggling with depression? NeuroStar TMS at Northeast Health Services offers safe, effective, FDA-cleared, non-drug ...
Philstar.com

Drug rehab center to be operational

After being idle for almost seven years, the Cebu Provincial Government has moved to revive its first province-run drug rehabilitation facility at the Dr. Jose Ma. V. Borromeo Memorial Hospital in ...

PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia

Under the agreement, PharmAla will provide its LaNeo™ MDMA at no charge to Spaulding Rehabilitation for use in a study entitled “Hyperscan Neuroimaging to Reveal the Brain Mechanisms Supporting ...

Syndax faces earnings test as cancer drug launches accelerate

Syndax Pharmaceuticals Inc. reports fourth-quarter results after the market close Thursday, with investors focused on whether the biotech’s recently launched cancer therapies can sustain commercial ...
PharmiWeb

Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of ...

INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...

What do eye doctors have to do with drug addiction? New Mass. research makes key connections

Eye doctors treating vision-threatening infections in drug users are uniquely positioned to connect patients with life-saving ...
Opinion
Sentinel & Enterprise on MSNOpinion

EDITORIAL: Drug settlement funds help state fight opioid crisis

Feb. 13—Getting your Trinity Audio player ready... Where does all that drug-settlement money go? In Massachusetts' case, it advances efforts that someday hopefully will preclude the need for such a ...

Boston leaders pitch new approach to tackle Mass and Cass drug market: ‘Status quo is not acceptable’

Boston community leaders proposed a new plan to tackle the open-air drug market at and around Mass and Cass that focuses on ...

Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial

Feb 17 (Reuters) - Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron's approved treatment Eylea in ...
STAT

Compass says its psilocybin drug helped patients with severe depression in two trials

Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to ...

FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...

US court revives Regenxbio patent lawsuit over muscular dystrophy treatment

Biotech company Regenxbio and the University of Pennsylvania on Friday convinced a U.S. appeals court to revive their patent lawsuit against Sarepta Therapeutics over Sarepta's Duchenne muscular ...